1 Shimazaki J, Sakata M, Tsuboto K. Ocular Surface Changes and Discomfort in Patients With Meibomian Gland Dysfunction. Arch Ophthalmol. 1995;113(10):1266-1270.
2Foulks GN. The correlation between the tear film lipid layer and dry eye disease. Surv Ophthalmol. 2007 Jul-Aug;52(4):369-74.
3Krenzer KL, Dana MR, Ullman MD, et al. Effect of androgen deficiency on the human meibomian gland and ocular surface. J Clin Endocrinol Metab. 2000 Dec;85(12):4874-82.
4Richards SM, Liu M, Jensen RV, et al. Androgen regulation of gene expression in the mouse lacrimal gland. J Steroid Biochem Mol Biol. 2005 Sep;96(5):401-13
5Foulks GN, Bron AJ. Meibomian gland dysfunction: a clinical scheme for description, diagnosis, classification, and grading. Ocul Surf. 2003 Jul;1(3):107-26.
6Henriquez AS, Korb DR. Meibomian glands and contact lens wear. Br J Ophthalmol. 1981 Feb;65(2):108-11.
7McCulley JP, Sciallis GF. Meibomian keratoconjunctivitis. Am J Ophthalmol. 1977 Dec;84(6):788-93.
8Mathers WD, Billborough M. Meibomian gland function and giant papillary conjunctivitis. Am J Ophthalmol 1992;114:188-92.
9Martin NF, Rubinfeld RS, Malley JD, Manzitti V. Giant papillary conjunctivitis and meibomian gland dysfunction blepharitis. CLAO J 1992;18:165-9.
10Friedman NJ. Impact of dry eye disease and treatment on quality of life. Curr Opin Ophthalmol. 2010 Jul;21(4):310-6.
11Clinical study data on file
12Yu J, Asche CV, Fairchild CJ. The economic burden of dry eye disease in the United States: A decision tree analysis. Cornea 2011;30(4):379-87
13Lemp MA and Nichols KK. Blepharitis in the United Stated 2009: A survey based perspective on prevalence and treatment. Ocul Surf 2009 Apr;7(2) Supplement:S1-22.
14Bron AJ, Yokoi N, Gafney E, Tiffany JM. Predicted phenotypes of dry eye: proposed consequences of its natural history. Ocul Surf. 2009 Apr;7(2):78-92
